These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 36406867

  • 1. Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada.
    Atiquzzaman M, Birks P, Bevilacqua M, Wong MMY, Zheng Y, Djurdjev O, Levin A.
    Can J Kidney Health Dis; 2022; 9():20543581221137177. PubMed ID: 36406867
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis.
    Fu X, Zhang S, Gao F, Mao N.
    Clin Nephrol; 2024 Oct; 102(4):223-231. PubMed ID: 38994592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease.
    Kim GH.
    Electrolyte Blood Press; 2019 Jun; 17(1):1-6. PubMed ID: 31338108
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of potassium binders in the treatment of patients with chronic kidney disease and hyperkalemia.
    Dong L, Xu W, Deng Y, Tan J, Qin W.
    Eur J Pharmacol; 2022 Sep 15; 931():175174. PubMed ID: 35964658
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative Efficacy of Sodium Zirconium Cyclosilicate and Sodium Polystyrene Sulfonate for Acute Hyperkalemia: A Retrospective Chart Review.
    Gonzalez J, Nayyar D.
    Hosp Pharm; 2024 Apr 15; 59(2):159-164. PubMed ID: 38450357
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J, Moffett BS.
    Pediatr Nephrol; 2016 Nov 15; 31(11):2113-7. PubMed ID: 27215929
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization.
    Desai NR, Rowan CG, Alvarez PJ, Fogli J, Toto RD.
    PLoS One; 2020 Nov 15; 15(1):e0226844. PubMed ID: 31910208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.